Medicine and human healthcare is the sector where major developments in the application of modern biotechnology have been achieved.

First and foremost, biotechnology provides instruments for research and development into new products and solutions. This includes genome, proteome, and metabolic studies, etc., to provide knowledge of the relationship between molecular biology and illnesses, increasing the possibility of finding new therapeutic solutions. Modern (bio)technologies have an impact in the validation phase of the solutions found, for example through the use of genetically modified animals. Nanotechnology applications can help develop more effective methods for product delivery.

This actually leads to: - finding more effective solutions with respect to those based on traditional methods, as well as therapeutic solutions for illnesses and problems never solved before, including cures for rare illnesses; - a reduction in the times required for medicine development, which are extremely long using traditional methods. In terms of economic impact, the main applications concern production activities, for which biotechnological developments provide more effective and efficient fermentative technologies, and the use of the so-called molecular farming, namely the production of substances grown in plants and animals.


  • (bio)medicine: macromolecules; biosimilar products (meaning medicines containing the same biomolecules as medicines that are no longer covered by patents); molecules of medium-small dimensions;
  • innovative therapeutic techniques: cell therapy, based also on stem cells; genetic therapy; therapies based on antisense and RNA interference; xenotransplants (production of genetically modified animals to supply organs for transplants);
  • vaccines, both preventive and therapeutic;
  • diagnostics, mainly using techniques based on proteins and nucleic acids (DNA/RNA).


There range of ailments involved is very wide: cardiovascular problems, diabetes, multiple sclerosis, cancer, leukaemia, AIDS, flu, malaria, hepatitis, neurodegenerative illnesses, allergies, etc.

The aim of pharmacogenetics is to find the most suitable therapy for a specific individual or group of people, on the basis of the genetic characteristics of the same. These studies are especially useful in the clinical experimentation of new medicines, as they help to select the most suitable sample of patients, establish the appropriate dosages and, as a consequence, minimize collateral effects.

In4Tech’s organization is composed of university researchers and experts in industrial plants, so that the company has the skills and expertise to operate in all the different stages involved with (bio)technology development and application (research, laboratory, pilot or semi-industrial plants, production plants). The technicians who collaborate with In4Tech are available to provide assistance worldwide.

<< Torna indietro